SBI Life Insurance Company Ltd
NSE:SBILIFE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 385.55
2 088
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
SBI Life Insurance Company Ltd
SBI Life Insurance Company Ltd., a joint venture between State Bank of India, the country's most prominent banking institution, and the French financial group BNP Paribas Cardif, stands as a formidable entity in India's burgeoning life insurance sector. Born out of a strategic collaboration in 2001, the company has since evolved into one of the top players in the industry, riding on its strong parentage and an extensive distribution network. At its core, SBI Life operates through various channels, including a robust network of individual agents, bancassurance partnerships, and direct sales, allowing it to reach a diverse customer base across urban and rural areas. The company's product portfolio spans traditional policies, unit-linked insurance plans (ULIPs), and various riders, tailored to meet the distinct needs of its clientele, from wealth creation and protection to securing their post-retirement life.
The company's revenue model is deeply rooted in the collection of premiums from its policyholders and the prudent investment of these funds. Premiums, both from new and renewal policies, form the primary stream of income, which is then sub-divided into a percentage that covers risk, administrative expenses, and profits. Meanwhile, like most insurance companies, SBI Life accrues substantial investment income from these premiums by channeling funds into a diversified asset portfolio that typically comprises government securities, equities, and bonds. While managing risk is paramount, the company leverages sophisticated actuarial and financial expertise to ensure optimal returns. In essence, SBI Life's financial strength and growth are a testament to its dual focus on securing the trust of its customers through reliable insurance products and continuously enhancing shareholder value through strategic investments.
SBI Life Insurance Company Ltd., a joint venture between State Bank of India, the country's most prominent banking institution, and the French financial group BNP Paribas Cardif, stands as a formidable entity in India's burgeoning life insurance sector. Born out of a strategic collaboration in 2001, the company has since evolved into one of the top players in the industry, riding on its strong parentage and an extensive distribution network. At its core, SBI Life operates through various channels, including a robust network of individual agents, bancassurance partnerships, and direct sales, allowing it to reach a diverse customer base across urban and rural areas. The company's product portfolio spans traditional policies, unit-linked insurance plans (ULIPs), and various riders, tailored to meet the distinct needs of its clientele, from wealth creation and protection to securing their post-retirement life.
The company's revenue model is deeply rooted in the collection of premiums from its policyholders and the prudent investment of these funds. Premiums, both from new and renewal policies, form the primary stream of income, which is then sub-divided into a percentage that covers risk, administrative expenses, and profits. Meanwhile, like most insurance companies, SBI Life accrues substantial investment income from these premiums by channeling funds into a diversified asset portfolio that typically comprises government securities, equities, and bonds. While managing risk is paramount, the company leverages sophisticated actuarial and financial expertise to ensure optimal returns. In essence, SBI Life's financial strength and growth are a testament to its dual focus on securing the trust of its customers through reliable insurance products and continuously enhancing shareholder value through strategic investments.
Premium Growth: SBI Life delivered strong growth with new business premium up 17% to INR 183.5 billion and gross written premium up 19% year-on-year.
Profitability: Profit after tax grew by 4% to INR 10.89 billion despite headwinds from revised GST rates.
Margins: Value of new business (VNB) margin improved by 98 bps to 27.8%, with management guiding to maintain margins in the 26% to 28% range even after GST changes.
Product Mix Shift: Strong performance in non-par, participating, and protection products, with protection segment APE growing 33% and new product launches gaining traction.
GST Impact: GST rate changes had a negative impact of 80 bps on H1 margins, but higher-margin products and operational efficiencies are expected to offset most of this going forward.
Distribution & Channel Recovery: Growth in banca and agency channels improved in September and is expected to continue in H2, alongside robust expansion in digital and other channels.
Guidance: Management reaffirmed full-year APE growth guidance of 13–14% and expects mid-teens growth from core channels in H2.